Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
Revisit the oncologic emergency, hypercalcemia of malignancy, including risk factors, manifestations, assessment, treatment, and nursing interventions.
Review this Huddle Card on the oncologic emergency disseminated intravascular coagulation (DIC). The card explores DIC’s risk factors, manifestations, assessment, treatment, and nursing interventions. This is a great educational resource for you and your colleagues.
Individually or within a group, review this card about the basic principles of cancer staging. This process is critical for treatment planning, eligibility for clinical trials, and treatment response.
Safe administration of high-risk anticancer medications requires careful calculation of ordered doses. Review this huddle card to understand how to calculate body surface area (BSA).
Review this huddle card to learn about altered body image in patients with cancer. Cancer treatments can affect physical appearance and cause functional changes to the body, which can adversely affect how people perceive and feel about their bodies.
Superior vena cava syndrome affects 3%-4% of patients with cancer involving the chest so patients with a diagnosis of lung cancer or non-Hodgkin lymphoma are at a higher risk. Explore the diagnostic assessments needed, emergency interventions, and clinical manifestations.
Enhance your knowledge of cytokine release syndrome and how it can affect patients with cancer. The incidence of CRS happening depends on the type of cancer therapy and diagnosis. You will learn about the risk factors, clinical manifestations, diagnosis assessment, emergency interventions and nursing considerations
A review on the types of diseases that HSCT can treat and the different types of HSCT treatments based on the donor and where the stem cells are derived. The intent of HSCT is to reduce or eliminate a patient’s own marrow spaces and replace and repopulate with healthy stem cells. This therapy provides the only currently known cure for some diseases.
Antimetabolites are cell cycle–specific anticancer agents that, when incorporated into RNA and DNA, exert their effects during a cell cycle’s synthesis phase. Review this huddle card in a group or individually to learn more about antimetabolites.
Nitrosoureas are a group of alkylating agents that cross the blood–brain barrier. The blood-brain barrier is a protective network of tissue and blood vessels made of tightly spaced cells that prevent harmful substances, such as toxins, pathogens, and certain medications, from reaching the brain.